From April 27 to 30, 2026, Sino Bioengineering participated in the BPI Europe Biotechnology Conference held in Vienna. Centering on the theme of Full-process Innovative Ecosystem, the company demonstrated the global vision of Chinese bioprocess solution providers. As an industry pacesetter, Sino Bioengineering adopted a modular booth design to systematically showcase its full-cycle biopharmaceutical process technology platform, delivering integrated solutions covering core segments including cell culture, separation & purification, formulation and filling.
During the exhibition, Sino Bioengineering consolidated its international brand image driven by technology and comprehensive services through live technical demonstrations and cross-border client case presentations. Its self-developed bioprocess technology system has drawn extensive attention from leading European pharmaceutical enterprises for its outstanding compatibility, superior stability and excellent scalability. In in-depth exchanges, the team engaged global partners in in-depth discussions on the standardization and intelligent development trends of bioprocesses, facilitating cross-regional technological collaboration and innovative development.
This exhibition has further consolidated Sino Bioengineering’s brand influence across the European market and strengthened its global supply chain cooperation network via strategic business dialogues. Moving forward, Sino Bioengineering will keep focusing on breakthroughs in core bioprocess technologies and build an open innovation ecosystem. By integrating cross-border resources and optimizing production capacity layout, the company will accelerate the upgrading of the global biopharmaceutical industry, and contribute Chinese expertise to fostering a more resilient global bioeconomic system.
